American International Group’s Asterias Biotherapeutics Warrants AST.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
– Sell
-1,222
Closed -$1K – 3101
2017
Q2
$1K Sell
1,222
-1
-0.1% – ﹤0.01% 3075
2017
Q1
$1K Hold
1,223
– – ﹤0.01% 2998
2016
Q4
$1K Hold
1,223
– – ﹤0.01% 3000
2016
Q3
$624 Hold
1,223
– – ﹤0.01% 3029
2016
Q2
$245 Buy
+1,223
New +$637 ﹤0.01% 3082

American International Group's AST.WS Position: Q3 2017 in Review

American International Group sold out of Asterias Biotherapeutics Warrants (AST.WS) in Q3 2017, closing a stake of 1,222 shares — an estimated $1K sold.

American International Group first reported a position in AST.WS in Q2 2016 and held it in 5 quarters. The position peaked at $1K in Q2 2017. 3 funds tracked by Wall St. Rank hold AST.WS as of Q3 2017.

  • American International Group reported no remaining Asterias Biotherapeutics Warrants position as of Q3 2017 after selling out during the quarter.
  • American International Group sold 1,222 Asterias Biotherapeutics Warrants shares in Q3 2017, an estimated $1K.
  • American International Group first reported a position in Asterias Biotherapeutics Warrants in Q2 2016 and held it in 5 quarters.
  • American International Group's Asterias Biotherapeutics Warrants position peaked at $1K in Q2 2017.
  • 3 funds tracked by Wall St. Rank held Asterias Biotherapeutics Warrants as of Q3 2017.

Based on American International Group's 13F filing for Q3 2017, filed 9 Nov 2017.